Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01091038 · ClinicalTrials.gov registry record · Phase 2
Improving Safety by Basic Computerizing Outpatient Prescribing
A Phase 2 study of Adverse Drug Events, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
- 228
- Enrollment target
- 2
- Study locations
NCT01091038: Completed Phase 2 study of Adverse Drug Events, sponsored by Indiana University.
NCT01091038 is a Phase 2 study of Adverse Drug Events that has completed, run by Indiana University. The registered enrollment target is 228 participants, below the 751-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01091038, a Phase 2 study of Adverse Drug Events, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 228 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will measure the effect of basic clinical decision support on medical errors and adverse drug events in the ambulatory setting.
Primary Outcome
Adverse drug events are measured through use of a computerized surveillance system augmented by focused structured human review
Conditions Studied
Interventions
- OTHER Routine Care
- OTHER Basic Clinical Decision Support
Study Locations (2)
Indiana
- Wishard Helath Services - Indianapolis
Massachusetts
- Partner's Healthcare - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2001-08 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
What the finished NCT01091038 record still lists
NCT01091038 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 751-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Adverse Drug Events appearing as the primary indexed condition, and to 2 interventions - of which Routine Care is the first listed.
NCT01091038 reports a single indexed study location in Indiana, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01091038 about?
NCT01091038 is a clinical study titled "Improving Safety by Basic Computerizing Outpatient Prescribing". The study will measure the effect of basic clinical decision support on medical errors and adverse drug events in the ambulatory setting.
What is the current status of trial NCT01091038?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 228 participants. The study started on 2001-08. Estimated completion is 2007-08.
What conditions does trial NCT01091038 study?
This clinical trial studies the following conditions: Adverse Drug Events.
What interventions are being tested in trial NCT01091038?
The interventions under investigation include: Routine Care (OTHER), Basic Clinical Decision Support (OTHER).
Who is sponsoring clinical trial NCT01091038?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01091038 being conducted?
This trial has 2 study locations across Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Drug Events
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Multi-Center Medication Reconciliation Quality Improvement Study
COMPLETED · NA
-
Response to Medication Registry
COMPLETED
-
Patient Profiling and Provider Feedback to Reduce Adverse Drug Events
COMPLETED · NA
-
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
COMPLETED · NA
-
Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia